Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial

已完结 10 由 用户anFcTA 发布于 2026-11-03 16:12
作者: Prof Annelies Van Rie PhD, Emilyn Costa Conceição PhD, Felex Ndebele MSc, Felicia Wells MSc, Astrid Paulse MSc, Eskedar Getie Mekonnen MSc, Miriam Ngarega MSc, Tu Pham Hien Trang MSc, Sthabiso Bohlela
文献类型: 期刊论文
补充材料: 只需要正文
Elsevier Elsevier
应助信息

求助已完结,文件已删除

如有需求请重新发布求助